LEU1_PSEA7
ID LEU1_PSEA7 Reviewed; 556 AA.
AC A6V0X2;
DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT 21-AUG-2007, sequence version 1.
DT 03-AUG-2022, entry version 78.
DE RecName: Full=2-isopropylmalate synthase {ECO:0000255|HAMAP-Rule:MF_00572};
DE EC=2.3.3.13 {ECO:0000255|HAMAP-Rule:MF_00572};
DE AltName: Full=Alpha-IPM synthase {ECO:0000255|HAMAP-Rule:MF_00572};
DE AltName: Full=Alpha-isopropylmalate synthase {ECO:0000255|HAMAP-Rule:MF_00572};
GN Name=leuA {ECO:0000255|HAMAP-Rule:MF_00572}; OrderedLocusNames=PSPA7_1323;
OS Pseudomonas aeruginosa (strain PA7).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC Pseudomonadaceae; Pseudomonas.
OX NCBI_TaxID=381754;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=PA7;
RA Dodson R.J., Harkins D., Paulsen I.T.;
RL Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Catalyzes the condensation of the acetyl group of acetyl-CoA
CC with 3-methyl-2-oxobutanoate (2-oxoisovalerate) to form 3-carboxy-3-
CC hydroxy-4-methylpentanoate (2-isopropylmalate). {ECO:0000255|HAMAP-
CC Rule:MF_00572}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=3-methyl-2-oxobutanoate + acetyl-CoA + H2O = (2S)-2-
CC isopropylmalate + CoA + H(+); Xref=Rhea:RHEA:21524, ChEBI:CHEBI:1178,
CC ChEBI:CHEBI:11851, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:57287, ChEBI:CHEBI:57288; EC=2.3.3.13;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_00572};
CC -!- PATHWAY: Amino-acid biosynthesis; L-leucine biosynthesis; L-leucine
CC from 3-methyl-2-oxobutanoate: step 1/4. {ECO:0000255|HAMAP-
CC Rule:MF_00572}.
CC -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_00572}.
CC -!- SIMILARITY: Belongs to the alpha-IPM synthase/homocitrate synthase
CC family. LeuA type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_00572}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000744; ABR86416.1; -; Genomic_DNA.
DR RefSeq; WP_012074569.1; NC_009656.1.
DR AlphaFoldDB; A6V0X2; -.
DR SMR; A6V0X2; -.
DR PRIDE; A6V0X2; -.
DR EnsemblBacteria; ABR86416; ABR86416; PSPA7_1323.
DR KEGG; pap:PSPA7_1323; -.
DR HOGENOM; CLU_004588_3_0_6; -.
DR OMA; DQIEYMH; -.
DR UniPathway; UPA00048; UER00070.
DR Proteomes; UP000001582; Chromosome.
DR GO; GO:0003852; F:2-isopropylmalate synthase activity; IEA:UniProtKB-UniRule.
DR GO; GO:0009098; P:leucine biosynthetic process; IEA:UniProtKB-UniRule.
DR CDD; cd07942; DRE_TIM_LeuA; 1.
DR Gene3D; 3.20.20.70; -; 1.
DR Gene3D; 3.30.160.270; -; 1.
DR HAMAP; MF_00572; LeuA_type2; 1.
DR InterPro; IPR013709; 2-isopropylmalate_synth_dimer.
DR InterPro; IPR002034; AIPM/Hcit_synth_CS.
DR InterPro; IPR013785; Aldolase_TIM.
DR InterPro; IPR005668; IPM_Synthase.
DR InterPro; IPR036230; LeuA_allosteric_dom_sf.
DR InterPro; IPR039371; LeuA_N_DRE-TIM.
DR InterPro; IPR000891; PYR_CT.
DR Pfam; PF00682; HMGL-like; 1.
DR Pfam; PF08502; LeuA_dimer; 1.
DR SMART; SM00917; LeuA_dimer; 1.
DR SUPFAM; SSF110921; SSF110921; 1.
DR TIGRFAMs; TIGR00970; leuA_yeast; 1.
DR PROSITE; PS00815; AIPM_HOMOCIT_SYNTH_1; 1.
DR PROSITE; PS00816; AIPM_HOMOCIT_SYNTH_2; 1.
DR PROSITE; PS50991; PYR_CT; 1.
PE 3: Inferred from homology;
KW Amino-acid biosynthesis; Branched-chain amino acid biosynthesis;
KW Leucine biosynthesis; Transferase.
FT CHAIN 1..556
FT /note="2-isopropylmalate synthase"
FT /id="PRO_1000025032"
FT DOMAIN 33..307
FT /note="Pyruvate carboxyltransferase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01151"
SQ SEQUENCE 556 AA; 61829 MW; EDB899397AD5C1F3 CRC64;
MSMLKDPSQK YRPFPAINLP DRTWPSKTIT EVPIWCSSDL RDGNQSLIEP MDAAKKMRFF
KTLVQVGLKQ IEVAFPSASD TDFNFVRELI EGNHIPDDVT IQVLTQARED LITRTFESLR
GAKKAIVHVY NATAPSFRRI VFNQDKQGVV DIATNAAKLI RKLAAEQPDT QWSFQYSPEI
FSSTELEFSV EVCNAVIDVW QPTPEHKIIL NLPATVECAT PNVYADQIEW FGRHVNRRDS
VIISLHTHND RGTGVAATEL GLMAGADRVE GCLFGNGERT GNVDLVTLAL NMYTQGLHPQ
LDFSDIDAVR KVVEECNQLP VHPRHPYVGD LVHTAFSGSH QDAIRKGFAQ QKEDAIWEVP
YLPIDPADIG RDYEAVIRVN SQSGKGGITF LLEQEYGISL PRRMQIEFSQ VVQGETDRLG
LEMTAQQIYS LLENEYLKAT SPYALASHRL QEENGTSAVD LEVTFDGEKQ HWRGIGKGPL
EALVAALPVK AEIMDYHEHA IGAGANARAA AYIEIRLEGQ RPLHGIGIDE NITTASFRAL
FSALNRAVTQ AEAKAA